165 related articles for article (PubMed ID: 25498536)
1. Licensed indication for risperidone in dementia.
Phizackerley D
BMJ; 2014 Dec; 349():g7337. PubMed ID: 25498536
[No Abstract] [Full Text] [Related]
2. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
Corbett A; Burns A; Ballard C
BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
[No Abstract] [Full Text] [Related]
3. Risperidone for Psychosis-Induced Aggression or Agitation.
Scruth E
Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
[No Abstract] [Full Text] [Related]
4. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
5. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
Aupperle P
Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
[TBL] [Abstract][Full Text] [Related]
6. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
[TBL] [Abstract][Full Text] [Related]
7. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
[TBL] [Abstract][Full Text] [Related]
8. Duration of risperidone treatment for BPSD.
Snowdon J; Brodaty H; Ames D; Day S
Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
[No Abstract] [Full Text] [Related]
9. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
De Deyn PP; Buitelaar J
Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
[TBL] [Abstract][Full Text] [Related]
10. Risperidone in the management of agitation in HIV dementia.
Lodge P; Tanner M; McKeogh MM
Palliat Med; 1998 May; 12(3):206-7. PubMed ID: 9743841
[No Abstract] [Full Text] [Related]
11. The effect of risperidone on nursing burden associated with caring for patients with dementia.
Asghar Ali AA; Espinoza R; Kavirajan H; Read S
J Am Geriatr Soc; 2005 Jul; 53(7):1261-2; author reply 1262-3. PubMed ID: 16108953
[No Abstract] [Full Text] [Related]
12. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
[TBL] [Abstract][Full Text] [Related]
13. Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.
Benoit M; Arbus C; Blanchard F; Camus V; Cerase V; Clement JP; Fremont P; Guerin O; Hazif Thomas C; Jeanblanc F; Lafont C; Moreaud O; Pedra M; Poncet M; Richard Harston S; Rigaud AS; Sotto Martin ME; Touchon J; Vellas B; Fitten LJ; Robert PH
J Nutr Health Aging; 2006; 10(5):410-5. PubMed ID: 17066213
[No Abstract] [Full Text] [Related]
14. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
15. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
Khan BU
J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
[No Abstract] [Full Text] [Related]
16. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Bogaisky M
Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109421
[No Abstract] [Full Text] [Related]
17. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
18. An unsubstantiated conclusion.
Reifler BV; Blazer D
Am J Geriatr Psychiatry; 2015 Feb; 23(2):220. PubMed ID: 25575935
[No Abstract] [Full Text] [Related]
19. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
